Curasight

Curasight, a Danish biotechnology company, is dedicated to developing gentler and more effective methods for cancer detection and treatment. Curasight's uPAR theranostic technology minimizes radiation to healthy tissues by combining targeted uTREAT® radiotherapy with precise uTRACE® diagnostics. Several Phase II clinical trials initiated by researchers have been completed or are currently underway.